Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback